Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. ETF
  3. MRK
MRK logo

MRK

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

MRK News

CMS Proposes Permanent Framework for Medicare Drug Price Negotiations

Jun 12 2026seekingalpha

Merck's PD-1 and HIF-2α Inhibitor Combination Approved

Jun 12 2026Newsfilter

Merck's Drug Receives FDA Label Expansion Approval

Jun 12 2026seekingalpha

Phibro Animal Health Corporation Earnings Analysis

Jun 11 2026NASDAQ.COM

Merck Acquires TARGAN to Expand Poultry Business

Jun 11 2026seekingalpha

Merck Animal Health Acquires TARGAN to Enhance Poultry Portfolio

Jun 11 2026NASDAQ.COM

U.S. Accelerates Response to New World Screwworm Outbreak

Jun 11 2026Newsfilter

GSK's $10.6 Billion Nuvalent Acquisition to Rebuild Cancer Drug Portfolio

Jun 11 2026Newsfilter

New World Screwworm Invasion Exacerbates Rising Beef Prices

Jun 10 2026CNBC

US Stocks Rebound as AI Trade Continues to Gain Momentum

Jun 09 2026NASDAQ.COM

Space Pharma Market Thrives Amidst Mega-IPO Frenzy

Jun 09 2026CNBC

Commercialization Prospects of Space Pharmaceuticals

Jun 09 2026Newsfilter

Merck and Gilead's Combination Pill Trials Achieve Primary Endpoint

Jun 08 2026seekingalpha

Merck and Gilead Discontinue Joint Study of Trodelvy and Keytruda

Jun 08 2026Newsfilter

Merck and Gilead Collaborate on Novel HIV Treatment

Jun 08 2026Newsfilter

Recommended High-Yield ETF: Schwab U.S. Dividend Equity ETF

Jun 06 2026Fool